Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | TACR2 | P21452 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SHBG | P04278 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL920409 | 0.98 | HTR2A (0.59) | HTR2ACA2SMN1; SMN2CA1ALDH1A1 | |
| SCHEMBL395434 | 0.93 | HTR2A (0.72) | HTR2ACA2ALDH1A1HSD17B10ESR1 | |
| SCHEMBL920406 | 0.91 | HTR2A (0.76) | HTR2ACA2ALDH1A1HSD17B10ESR1 | |
| SCHEMBL29285307 | 0.91 | HTR2A (0.76) | HTR2ACA2ALDH1A1HSD17B10ESR1 | |
| SCHEMBL29038707 | 0.91 | HTR2A (0.76) | HTR2ACA2ALDH1A1HSD17B10ESR1 | |
| SCHEMBL393623 | 0.91 | HTR2A (0.76) | HTR2ACA2ALDH1A1HSD17B10ESR1 | |
| SCHEMBL395308 | 0.91 | HTR2A (0.76) | HTR2ACA2ALDH1A1HSD17B10ESR1 | |
| SCHEMBL394553 | 0.91 | HTR2A (0.76) | HTR2ACA2ALDH1A1HSD17B10ESR1 | |
| Hydrochloric Acid SCHEMBL1856278 | 0.91 | HTR2A (0.69) | HTR2ACA2ALDH1A1HSD17B10ESR1 | |
| SCHEMBL2674306 | 0.91 | HTR2A (0.76) | HTR2ACA2ALDH1A1HSD17B10ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111423837-A | TPU hot melt adhesive and preparation method thereof | 上海抚佳精细化工有限公司 | 2020-07-17 | — | — | CN | claimed |
| CN-106480735-B | Circuit substrate and preparation method thereof | 广东生益科技股份有限公司 | 2019-06-14 | — | — | CN | claimed |
| US-20170305859-A1 | An Anticonvulsant Compound | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2017-10-26 | — | — | US | claimed |
| EP-3191088-A1 | AN ANTICONVULSANT COMPOUND | Royal Holloway And Bedford New College (GB) | 2017-07-19 | — | — | EP | claimed |
| CN-103980706-B | Thermosetting resin composition and applications thereof | 广东生益科技股份有限公司 | 2017-01-11 | — | — | CN | claimed |
| WO-2016038379-A1 | AN ANTICONVULSANT COMPOUND | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2016-03-17 | — | — | WO | claimed |
| US-20070066682-A1 | Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus | GENMEDICA THERAPEUTICS SL (ES) | 2007-03-22 | — | — | US | claimed |
| WO-2025052776-A1 | METHOD FOR MANUFACTURING SURFACE-TREATED SUBSTRATE, METHOD FOR SELECTIVELY MODIFYING SUBSTRATE SURFACE, AND COMPOSITION FOR SEMICONDUCTOR TREATMENT | JSR株式会社 | 2025-03-13 | — | — | WO | disclosed |
| CN-112280251-B | High-performance amine curing system epoxy asphalt material and preparation method thereof | 南京阿斯孚特新材料科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20220112242-A1 | SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME | CDRD VENTURES INC. (CA) | 2022-04-14 | — | — | US | disclosed |
| CN-111423837-B | TPU hot melt adhesive and preparation method thereof | 上海抚佳精细化工有限公司 | 2022-04-05 | — | — | CN | disclosed |
| EP-3177611-B1 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | NUEVOLUTION AS (DK) | 2021-10-06 | — | — | EP | disclosed |
| CN-112280251-A | High-performance amine curing system epoxy asphalt material and preparation method thereof | 南京阿斯孚特新材料科技有限公司 | 2021-01-29 | — | — | CN | disclosed |
| US-5003106-A | Antiatherosclerotic ureas and thioureas | AMERICAN CYANAMID COMPANY (US) | 1991-03-26 | — | — | US | disclosed |
| EP-0381141-A2 | Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions | MERRELL PHARMACEUTICALS INC. (US) | 1990-08-08 | — | — | EP | disclosed |
| EP-0381142-A2 | Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-08-08 | — | — | EP | disclosed |
| US-4861777-A | Pyrazole derivative and insecticidal and miticidal composition containing the derivative as active ingredient | MITSUBISHI KASEI CORPORATION (JP) | 1989-08-29 | — | — | US | disclosed |
| EP-0307801-A1 | Pyrazole derivative and insecticidal and miticidal composition containing the derivative as active ingredient | MITSUBISHI KASEI CORPORATION (JP) | 1989-03-22 | — | — | EP | disclosed |
| US-4623662-A | ANTICHOLESTEROL, ANTILIPEMIC | AMERICAN CYANAMID COMPANY (US) | 1986-11-18 | — | — | US | disclosed |
| US-4094982-A | PYRIDINE SULFONAMIDES AND THEIR USE AS ANTICOCCIDIAL AGENTS | SANKYO COMPANY LIMITED (JA) | 1978-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066682-A1 | Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus | GPR119, ABCC1, INSR | HTR2A 729/4885CA2 1235/4885SMN1; SMN2 3891/4885 |
| US-20170305859-A1 | An Anticonvulsant Compound | PSEN2, BACE2, APP | HTR2A 551/4885CA2 336/4885SMN1; SMN2 1964/4885 |
| US-20220112242-A1 | SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME | GPR119, SSTR5, SSTR2 | HTR2A 410/4885CA2 326/4885SMN1; SMN2 1277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.